| Peeran D Sandhu, MD | |
|
511 S Santa Fe Ave, Suite 200, Salina, KS 67401-4145 | |
| (785) 452-4860 | |
| (785) 452-4878 |
| Full Name | Peeran D Sandhu |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 511 S Santa Fe Ave, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003957788 | NPI | - | NPPES |
| 200739100B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-35237 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salina Regional Health Center | Salina, KS | Hospital |
| Cloud County Health Center | Concordia, KS | Hospital |
| Memorial Hospital | Abilene, KS | Hospital |
| Lindsborg Community Hospital | Lindsborg, KS | Hospital |
| Clay County Medical Center | Clay center, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Salina Regional Health Center Inc | 0446168215 | 138 |
News Archive
In early January 2021, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified from travelers returning from Brazil. This variant, referred to as "P.1", likely emerged in early-to-late November 2020, and subsequently spread throughout Manaus, the state capital of Amazonas, Brazil, over the following December.
BioSphere Medical, Inc. - the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today reported that it has entered into an a definitive agreement and plan of merger with Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co. in a cash transaction valued at approximately $96 million.
Patients with chronic pain caught between cardiovascular concerns about non-opioid analgesics and addiction risks of opioids, likely causing significant unmet need for pain relief.
Today, the New York Stem Cell Foundation Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development. Cell lines generated by NYSCF will complement genomic data and medical histories contributed by participants in the Harvard Personal Genome Project, creating a unique and powerful resource to help researchers identify causes of disease.
› Verified 5 days ago
| Entity Name | Salina Regional Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619952785 PECOS PAC ID: 0446168215 Enrollment ID: O20040130000800 |
News Archive
In early January 2021, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified from travelers returning from Brazil. This variant, referred to as "P.1", likely emerged in early-to-late November 2020, and subsequently spread throughout Manaus, the state capital of Amazonas, Brazil, over the following December.
BioSphere Medical, Inc. - the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today reported that it has entered into an a definitive agreement and plan of merger with Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co. in a cash transaction valued at approximately $96 million.
Patients with chronic pain caught between cardiovascular concerns about non-opioid analgesics and addiction risks of opioids, likely causing significant unmet need for pain relief.
Today, the New York Stem Cell Foundation Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development. Cell lines generated by NYSCF will complement genomic data and medical histories contributed by participants in the Harvard Personal Genome Project, creating a unique and powerful resource to help researchers identify causes of disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peeran D Sandhu, MD 511 S Santa Fe Ave, Salina, KS 67401-4145 Ph: (785) 452-7269 | Peeran D Sandhu, MD 511 S Santa Fe Ave, Suite 200, Salina, KS 67401-4145 Ph: (785) 452-4860 |
News Archive
In early January 2021, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified from travelers returning from Brazil. This variant, referred to as "P.1", likely emerged in early-to-late November 2020, and subsequently spread throughout Manaus, the state capital of Amazonas, Brazil, over the following December.
BioSphere Medical, Inc. - the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today reported that it has entered into an a definitive agreement and plan of merger with Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co. in a cash transaction valued at approximately $96 million.
Patients with chronic pain caught between cardiovascular concerns about non-opioid analgesics and addiction risks of opioids, likely causing significant unmet need for pain relief.
Today, the New York Stem Cell Foundation Research Institute and PersonalGenomes.org announced a partnership to identify genetic and environmental contributions to trait and disease development. Cell lines generated by NYSCF will complement genomic data and medical histories contributed by participants in the Harvard Personal Genome Project, creating a unique and powerful resource to help researchers identify causes of disease.
› Verified 5 days ago
Dr. William F Cathcart-rake, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 511 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-7261 | |
Dr. William R Alsop, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 737 E Crawford St, Salina, KS 67401 Phone: 785-827-7261 | |
Dr. Carolyn Annette Hofer, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1410 E Iron Ave, Suite 1, Salina, KS 67401 Phone: 785-826-1580 | |
Jeffrey M. Geitz, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 511 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-4860 Fax: 785-452-4878 | |
Dr. Kent B. Berquist, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 520 S Santa Fe Ave, Suite 120, Salina, KS 67401 Phone: 785-452-7325 Fax: 785-452-6570 | |
Dr. Michael K. Lawrence, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 501 S Santa Fe Ave, Suite 200, Salina, KS 67401 Phone: 785-452-7269 Fax: 785-452-7566 |